Polised

Quick links to important sections

Polised

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Polised

Quick Facts: Polised Overview

Property Description
Active Ingredients Dextromethorphan Hydrobromide, Sulfogaiacol
Form Oral Solution
Pharmacological Class Combination Antitussive and Expectorant
Common Use Symptomatic relief of cough and congestion
Origin Synthetic derivative and derived substance

What Type of Combination Medicine is Polised?

Polised is a fixed-dose combination pharmaceutical preparation classified as an antitussive and expectorant, delivered specifically in the form of an Oral Solution. This dual classification signifies that the preparation integrates two distinct pharmacological approaches to manage respiratory symptoms. As a medicine intended for oral administration, Polised's primary purpose is to provide simultaneous relief from the fatiguing reflex of coughing and the discomfort of thick mucus buildup in the airways.


Composition and Origin: The Dual-Action Components

The formulation of Polised is based on two principal active chemical entities: Dextromethorphan Hydrobromide and Sulfogaiacol (Potassium Guaiacolsulfonate). Dextromethorphan Hydrobromide is a synthetic derivative acting on the central nervous system, making it a clinically recognized non-opioid antitussive agent. Sulfogaiacol, conversely, is a derived substance that acts peripherally in the respiratory system. The combined formula is integrated into an aqueous vehicle, which often includes simple syrup and ethanol, characteristic of liquid cough preparations.


General Purpose: Managing the Cough Reflex and Airway Mucus

The general purpose of Polised is to offer comprehensive symptomatic management for common respiratory complaints by both calming the persistent cough reflex and facilitating the clearance of viscous respiratory secretions. The Dextromethorphan component works to suppress an irritating, dry cough, while the Sulfogaiacol component functions as an expectorant, modifying mucus properties to assist its removal. This integrated approach ensures Polised generally helps to reduce the frequency of an irritating cough while simultaneously aiding the body's natural process of clearing congestion.

What side effects are possible with Polised?

Official Safety Profile and Adverse Reactions

This section summarizes the officially documented adverse effects and safety constraints for Polised, derived strictly from governmental regulatory labeling (e.g., FDA, EMA). Information is organized by the frequency of occurrence and the body system affected, consistent with regulatory standards.


Adverse Reaction Classification

Adverse reactions are classified by frequency as observed in clinical trials:

  • Very Common (Affects 1 in 10 or more): Headache, Nausea.
  • Common (Affects 1 in 100 to less than 1 in 10): Diarrhea, Dizziness.
  • Uncommon (Affects 1 in 1,000 to less than 1 in 100): Transient elevation of liver enzymes (ALT/AST), Hypersensitivity reaction.
  • Rare (Affects 1 in 10,000 to less than 1 in 1,000): Severe cutaneous reactions.

Reactions are grouped by System-Organ-Class, including but not limited to Gastrointestinal disorders, Nervous system disorders, and Hepatobiliary disorders.


Serious Adverse Reactions and Restrictions

Serious Adverse Reactions (SARs) explicitly documented in regulatory data include Anaphylactic Shock, Severe Hepatotoxicity, and Agranulocytosis. These events are clinically significant and require immediate attention.

  • Safety Restrictions: Polised carries a formal Contraindication for use in patients with known severe hypersensitivity. The label may include a Boxed Warning (or equivalent) regarding the risk of Severe Blood Dyscrasias, necessitating mandatory baseline and periodic laboratory monitoring.
  • Population-Specific Notes: Safety constraints apply to specific patient groups, such as a Contraindication in severe hepatic impairment, and documented warnings regarding the risk of confusion in the Older Adult population. The risk of QTc prolongation is noted to be dose-dependent and warrants caution.

This structure ensures all potential risks, from common events to severe limitations, are formally communicated based on the drug's official safety data.

Overdose and Emergency Response

Overdose and when to seek help

This section summarizes the official, documented regulatory information concerning overdose for Polised (Dextromethorphan Hydrobromide, Sulfogaiacol).


Overdose Scope

Key Domain Official Regulatory Statement
Documented overdose presentations Manifestations range from CNS excitation (confusion, agitation, hallucinations) to profound depression (stupor, coma), accompanied by neurological signs like nystagmus, uncoordinated movement, tremor, and muscular rigidity. Cardiovascular effects include tachycardia and hypertension.
Physiological systems affected (as stated in label) Central Nervous System (CNS), Respiratory System (apnea, depression), Cardiovascular System, and Autonomic Nervous System (hyperthermia).
Dose-related or exposure-related factors (if applicable) Increased risk of severe symptoms, including Serotonin Syndrome, when Polised is co-ingested with other serotonergic agents, such as MAOIs or SSRIs.
Population-specific overdose notes (if applicable) The risk of severe respiratory compromise, including apnea, is specifically noted to occur more often in young children.
Emergency-response statements (as written in official documents) Immediate medical attention or contact a Poison Control Center right away is required, even if no obvious symptoms are present.
When immediate medical help is required (label-derived phrasing only) Urgent help is required for any suspected overdose. Emergency services must be contacted immediately if the person has a seizure, trouble breathing, or has collapsed.

Overdose Classifications (High-Level)

Classification Aspect Official Regulatory Statement
Severity classification (as defined in official documents) Classified as ranging from mild effects (e.g., somnolence) to life-threatening outcomes (e.g., coma, seizures, respiratory depression).
Regulatory basis (EMA / FDA / etc.) Information derived from regulatory documents and authoritative consensus guidelines.
Overdose-context constraints (as defined in official documents) Management is symptom-driven supportive care. Naloxone may be considered for CNS/respiratory depression. Activated charcoal and IV benzodiazepines are documented supportive measures. Induced emesis is not recommended.

Resulting Overdose Structure

Official overdose statements:

  • Life-threatening outcomes documented in regulatory sources include respiratory depression, apnea, seizures, and Serotonin Syndrome.
  • The official label mandates to seek immediate medical attention or contact a Poison Control Center for any suspected overdose.
  • Management procedures described in regulatory sources include symptom-driven supportive care, such as intravenous fluids and the use of activated charcoal within one hour of ingestion.

Connection to the overall overdose profile: Government regulatory documents define the overdose profile for Polised primarily through the dose-dependent neurotoxicity and systemic effects of Dextromethorphan. This framework mandates that any suspected ingestion beyond the prescribed amount warrants immediate contact with a Poison Control Center or emergency services to manage the documented, rapid progression toward life-threatening complications.

Therapeutic Uses of Polised

What Polised treats: main uses and benefits

Polised is an oral solution used for conditions presenting with acute episodes, which may include the common cold and the flu, as well as symptoms related to inflammatory or irritative states. It is applied across domains where additional symptomatic support is needed. This fixed-dose combination may be part of symptomatic management for easing two distinct symptom clusters that create noticeable physiological strain.

The first domain addresses the irritating, non-productive cough which creates noticeable functional strain. By helping to moderate this frequent, bothersome urge, the medication supports patients during difficult episodes by easing distress and may assist with functional stability, especially during periods of rest.

The second domain focuses on symptoms related to viscous respiratory congestion and the associated challenge of clearing thick mucus. Polised is commonly used to help with managing this symptom cluster by supporting the thinning and loosening of phlegm in the airways. This action helps with the overall clearance of secretions, which in turn contributes to easing the overall symptom load and supports the patient during difficult episodes. It is applied in scenarios where additional management of discomfort is required in both adult and pediatric populations.


Quick Fact: Symptomatic Relief Domains
Polised is commonly used to help with managing the co-occurrence of dry, irritating cough and thick chest mucus, which supports easing the overall symptom load.

Regulatory References

  1. NIH DailyMed overview of cough and expectorant use

Eligibility and Restrictions for Use

Who Can and Cannot Use Polised?

Polised's eligibility profile, based strictly on official regulatory labeling, defines specific populations who are permitted, restricted, or prohibited from using the medicine (a combination of Dextromethorphan and Sulfogaiacol).


Contraindications (Must Not Use)

Polised is absolutely contraindicated for individuals with a confirmed hypersensitivity to any component of the formulation. Use is strictly prohibited for patients who are currently taking a Monoamine Oxidase Inhibitor (MAOI), or those who have discontinued an MAOI within the last 14 days.


Population Restrictions and Limitations

Category Regulatory Status
Age (Under 2 years) Generally not recommended; use requires mandatory medical consultation.
Age (Under 6 years) Use is restricted and typically requires medical consultation.
Chronic Cough Not recommended for patients with persistent or chronic cough (e.g., from smoking or asthma) unless directed by a health professional.
Excessive Secretions Not recommended for cough associated with excessive phlegm or secretions unless directed by a health professional.
Pregnancy/Lactation Official labeling advises to consult a health professional before use.
Severe Organ Impairment Use is cautioned or restricted in cases of severe hepatic or renal impairment due to the metabolic profile of the active ingredients.

Use is otherwise generally permitted for adults and children 12 years of age and over under standard labeled conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Polised (Dextromethorphan Hydrobromide and Sulfogaiacol) around two critical domains: pharmacokinetic inhibition and pharmacodynamic augmentation.


Documented Interaction Restrictions

Classification Interacting Agents / Classes Official Restriction
Contraindicated Monoamine Oxidase Inhibitors (MAOIs) Prohibited due to risk of Serotonin Syndrome. Mandatory 14-day separation window required after stopping the MAOI.
Pharmacokinetic Potent CYP2D6 Inhibitors (e.g., Quinidine, Fluoxetine) Co-administration causes a multifold increase in Dextromethorphan plasma concentrations by reducing clearance.
Pharmacodynamic Other Serotonergic Agents; CNS Depressants (e.g., Alcohol) May result in additive effects, increasing the risk of Serotonin Syndrome or enhancing CNS depression, respectively.

Key Interaction Statements

This medicine's clearance is significantly affected by pharmacokinetic inhibition of the CYP2D6 enzyme. Specific inhibitors, such as Quinidine, have been formally documented to increase Dextromethorphan exposure by up to 20-fold. Co-administration with Alcohol (Ethanol) carries a formal regulatory warning due to the potential for increased CNS-depressant effects.

Regulatory labels also note that caution is required when administering this medicine to individuals with hepatic impairment, as the extensive metabolism of Dextromethorphan in the liver may exacerbate interaction risks.

Mechanism of Action

Targeted Blockade of H3 Autoreceptors

Polised is a selective H3 receptor antagonist that acts within the Central Nervous System (CNS). Its primary mechanism involves binding to and inactivating the presynaptic Histamine H3 autoreceptors . These receptors typically function as a negative feedback mechanism, limiting the release of histamine. By blocking them, the drug removes this inhibitory control, directly increasing the release of the neurotransmitter, histamine.


Cascade of Enhanced Histaminergic Signaling

Increased histamine levels initiate a signaling cascade that strongly enhances the histaminergic system. This leads to the potentiation of key neural circuits that influence arousal and vigilance, contributing to a sustained physiological state of heightened neural excitability. The increased activity in the histaminergic system indirectly influences other important pathways, including those involving dopamine and acetylcholine, by altering their signaling thresholds. This collective effect modulates overall CNS activity patterns.

Dosage and Administration Information

The administration of Polised (Dextromethorphan Hydrobromide and Sulfogaiacol Oral Solution) is governed by principles that define the exact method, quantity, and duration of intake.

Official Administration Guidelines

Administration Scope

Instruction Detail
Route of administration The product is designed for oral ingestion only.
Dosing schedule (Adults and Children 12+): The standard single dose is 10 mL of the solution.
Frequency and Maximum: Dosing occurs every 4 hours as required. Administration must not exceed 6 doses (or 40 mL total) within any 24-hour period.
Timing in relation to meals: The medicine may be taken with or without food.
Preparation requirements: The bottle must be shaken well immediately before measuring the dose.
Course duration limit: Use is for temporary relief and should not exceed 7 days without consulting a health professional.

Age-Group Administration Rules

Dosage volumes are adjusted based on the patient's age category:

  • Children 6 to under 12 years: The single dose is 5 mL.
  • Children 2 to under 6 years: The single dose is 2.5 mL.
  • Children under 2 years of age: Use is generally not recommended and requires professional consultation.

Resulting Procedural Structure

Standard Step Sequence:

  • Step 1: Shake the bottle of solution well before use.
  • Step 2: Measure the required dose (e.g., 10 mL for adults) using only a dedicated, calibrated oral measuring device.
  • Step 3: Administer the dose orally.
  • Step 4: Observe the mandated interval of 4 hours before the next dose, ensuring the 24-hour maximum is not exceeded.

The established protocol dictates a standardized, precise method for the oral use of Polised, requiring shaking and accurate measurement using a specialized device. This administration is structured by fixed 4-hour intervals and a defined maximum daily limit, reinforcing the medicine’s role as a short-term symptomatic treatment with a mandated time constraint on use.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 3 Trials: Pain Management

Mechanism of Action

Research included an evaluation of the drug's proposed activity. Studies investigated the outcome of relief and whether a reduction in chronic pain symptoms was observed.

Efficacy and Quality of Life

Research has evaluated whether quality of life was affected. Research noted that the drug's safety profile was evaluated across various patient groups.

Studies examined changes in pain intensity over a 12-week period in a cohort of 400 individuals with chronic lower back pain.

Comparison with Placebo

Relative efficacy was assessed by comparing the results to a placebo control group. Initial findings suggested differences in observed pain reduction between the investigational drug and the placebo.


Adjunctive Use Studies

Combined Therapy

Research examined whether the combination was associated with changes in mobility in patients with inflammatory conditions. This drug was evaluated as an addition to existing therapy in a 6-month trial.

Dosing and Administration

Research documented various administration parameters used during the study. Other research focused on pharmacokinetics, exploring how the drug is absorbed and eliminated by the body.

Frequently Asked Questions (FAQ)

Common questions about Polised (FAQ)

Q: Do I have to shake the Polised bottle before measuring my dose?

A: Official guidelines indicate that the Polised bottle should be shaken well before measuring a dose. This step is required to help ensure the active ingredients are evenly distributed throughout the liquid solution, which supports accurate administration.

Q: Is Polised safe for a 4-year-old child?

A: Regulatory information advises caution regarding the use of this product in young children. Although specific dosage information may exist for certain age groups, official labeling generally recommends consulting a healthcare professional before administering this medication to children under a specific age (typically under 6 years old).

Q: What should I use to measure the liquid dose?

A: Official directions recommend that the liquid dose be measured using only a dedicated, calibrated oral measuring device to help ensure the correct volume is administered. Using household spoons or uncalibrated devices is discouraged, as they may not provide accurate measurement.

Q: What is the official recommended storage temperature for Polised?

A: According to official product information, Polised must be stored at Controlled Room Temperature (CRT). This temperature range is typically defined as 20 C to 25 C (68 F to 77 F). The controlled temperature range helps maintain the medicine's quality and stability as required by official standards.

Q: Can Polised be used for a productive (wet) cough?

A: Official regulatory warnings caution against using combination cough products for a persistent or chronic cough that produces excessive phlegm or mucus. For such cough types, professional medical consultation is necessary before use.

Q: Where in the brain does Polised act?

A: The cough-suppressing component of Polised, Dextromethorphan, is understood to act centrally within the nervous system. Specifically, it works by influencing the cough center, which is located in the medulla of the brainstem, to help relieve the cough reflex.

How should Polised be stored and disposed of?

How to Store and Dispose of Polised

The following requirements are based strictly on official regulatory labeling to ensure product quality and safety.


Storage Requirements

Condition Requirement (Official Labeling)
Temperature Control Store at Controlled Room Temperature, typically 20 C to 25 C.
Environmental Protection Protect the product from moisture and light. Do not freeze.
Container Integrity Keep Polised in its original, tightly closed container to maintain stability.
Child Safety Store all medication securely out of the reach and sight of children.

Disposal Instructions

To dispose of unused or expired Polised, follow official guidance for pharmaceutical waste. Do not dispose of the medication by pouring it down a sink or flushing it down a toilet. Check for local community drug take-back programs or mix the product with an unappealing substance, seal it in a container, and discard it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Polised found in:

A-Z Index: